NASDAQ:INBS

Intelligent Bio Solutions - INBS Stock Forecast, Price & News

$0.82

-0.14 (-14.60%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.75
▼
$0.88
50-Day Range: $0.19
▼
$1.24
52-Week Range: $0.17
▼
$1.60

Volume: 2.05 million shs
Average Volume: 9.52 million shs
Market Capitalization: $15.03 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Intelligent Bio Solutions (NASDAQ:INBS) Stock

Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Stock News Headlines

January 27, 2023 | americanbankingnews.com

Reviewing Intelligent Bio Solutions (INBS) and Its Peers

January 23, 2023 | finanznachrichten.de

Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development

January 29, 2023 | Porter & Company (Ad)

Is This The End of Capitalism?

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

January 23, 2023 | marketwatch.com

Intelligent Bio Sees Improvement in Biosensor-Platform Development Study

January 23, 2023 | marketwatch.com

Intelligent Bio Shares Quadruple After Improvement in Biosensor-Platform Development

January 23, 2023 | finance.yahoo.com

Intelligent Bio Solutions Reaches Key Milestone in Biosensor Platform Development

January 22, 2023 | americanbankingnews.com

Comparing Intelligent Bio Solutions (INBS) & The Competition

January 21, 2023 | morningstar.com

Intelligent Bio Solutions Inc Ordinary Shares

January 29, 2023 | Porter & Company (Ad)

Is This The End of Capitalism?

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

January 5, 2023 | finance.yahoo.com

INBS: It’s Touch and Go From Here

January 5, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights

January 5, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Cancellation of FY 2021 Annual Meeting of Stockholders

January 5, 2023 | finance.yahoo.com

Intelligent Bio Solutions Inc. Announces Closing of Private Placement Offering

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive INBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter.

INBS Company Calendar

Today: 1/29/2023
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:INBS
CUSIP: N/A
CIK: 1725430
Web: gbs.inc
Phone: 646-828-8258
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.56)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,310,000.00
Net Margins: -1,078.91%
Pretax Margin: -1,082.78%
Return on Equity: -106.09%
Return on Assets: -62.08%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.48
Quick Ratio: 3.48

Sales & Book Value

Annual Sales: $440,000.00
Price / Sales: 34.16
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.44 per share
Price / Book: 1.86

Miscellaneous

Outstanding Shares: 18,350,000
Free Float: 18,006,000
Market Cap: $15.03 million
Optionable: Not Optionable
Beta: 1.47

Key Executives

Mr. Harry Simeonidis (Age 55)
Pres & CEO
Comp: $354.71k

Mr. Spiro Kevin Sakiris B.Bus (Age 60)
C.A., CA, Dip Law, Chief Financial Officer
Comp: $292.45k

Ms. Victoria Gavrilenko (Age 39)
Operations Mang.

Mr. Alex Arzeno
VP of Investor Relations

Key Competitors

View All Competitors

INBS Stock - Frequently Asked Questions

How have INBS shares performed in 2023?: Intelligent Bio Solutions' stock was trading at $0.1999 on January 1st, 2023. Since then, INBS stock has increased by 309.7% and is now trading at $0.8190.
View the best growth stocks for 2023 here.
What is Intelligent Bio Solutions' stock symbol?: Intelligent Bio Solutions trades on the NASDAQ under the ticker symbol "INBS."

How do I buy shares of Intelligent Bio Solutions?: Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Intelligent Bio Solutions' stock price today?: One share of INBS stock can currently be purchased for approximately $0.82.
How much money does Intelligent Bio Solutions make?: Intelligent Bio Solutions (NASDAQ:INBS) has a market capitalization of $15.03 million and generates $440,000.00 in revenue each year. The company earns $-8,310,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis.
How can I contact Intelligent Bio Solutions?: Intelligent Bio Solutions' mailing address is 142 WEST 57TH ST FL11, NEW YORK NY, 10019. The official website for the company is gbs.inc. The company can be reached via phone at 646-828-8258 or via email at investor.relations@gbs.inc.

This page (NASDAQ:INBS) was last updated on 1/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Intelligent Bio Solutions - INBS Stock Forecast, Price & News

About Intelligent Bio Solutions (NASDAQ:INBS) Stock

INBS Stock News Headlines

INBS Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

INBS Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info